首页>
外国专利>
TREATMENT OF CANCERS USING ANTI-EMP2 ANTIBODY AND PD-1/PDL-1 PATHWAY ANTAGONIST COMBINATION THERAPY
TREATMENT OF CANCERS USING ANTI-EMP2 ANTIBODY AND PD-1/PDL-1 PATHWAY ANTAGONIST COMBINATION THERAPY
展开▼
机译:抗EMP2抗体和PD-1 / PDL-1通路拮抗剂联合治疗的癌症治疗
展开▼
页面导航
摘要
著录项
相似文献
摘要
Provided herein are compositions and methods for the treatment of a cancer in a subject having such a cancer (e.g., a breast cancer). In particular, the compositions provided herein include an anti-EMP2 antibody and a PD-1/PD-L1 pathway antagonist.
展开▼